With legal, accounting and MBA qualifications, Mr. Cameron has high-level international taxation and commercial law experience in the UK, Hong Kong and Europe with Denton Hall Burgin (now Dentons). He has had significant business, board and commercialization experience as Chairman, CEO and managing director of Gribbles Pathology which became Australasia’s largest pathology services provider and a global pathology, diagnostic and analytical services and molecular science company. Mr. Cameron guided Gribbles through a successful exit with Healthscope in 2004. Since this sale, he has invested in Biotechnology ventures in Australia and globally.